Pre-GMP Facility
1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease
- Contribution to journal › Article
-
Mark
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease : a phase 1/2 open-label trial
(2026) In Nature Medicine
- Contribution to journal › Article
